FDA Drug Recalls

Recalls / Class III

Class IIID-0051-2018

Product

Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;

Affected lot / code info
Lot # DR10635, EXP 05/2019; DR10636, EXP 05/2019.

Why it was recalled

Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

Recalling firm

Firm
Wockhardt Usa Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
20 Waterview Blvd Ste 3, N/A, Parsippany, New Jersey 07054-1271

Distribution

Quantity
5050 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2017-08-22
FDA classified
2017-10-26
Posted by FDA
2017-11-01
Terminated
2019-02-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0051-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls